Innovation Endeavors and the LEO Science & Tech Hub kick off a Deep Life Challenge program. Allergan Aesthetics, an AbbVie company, and Skinbetter Science launch a new long-term, educational initiative: The DREAM (Driving Racial Equity in Aesthetic Medicine) Initiative. The San Diego Dermatology Symposium inaugural meeting adopts a virtual format to deliver updates on topics ranging from acne, rosacea and psoriasis to skin cancer diagnosis and social media.
What is the latest on sunscreen labeling? What are implications of recent serology studies? And could new screening agents come to the US market? Host Joel L. Cohen, MD talks to Terri Michele, MD, Director of the Office of Nonprescription Drugs in FDA CDER about these and other hot topics in sun protection.
Galderma's Restylane Kysse is now FDA approved for lip augmentation and the correction of wrinkles around the upper lips in adults. Americans understand that sunscreen use is important to protect the skin, but they still don’t use SPF regularly, AAD data reveal. AbbVie has completed its acquisition of Allergan.
Mattel has introduced several new dolls as part of its "Fashionista" line for 2020, including a doll with alopecia and one with vitiligo. Jeanine Downie, MD weighs in. Maui Derm 2020 offers insights on new and emerging therapies for acne, skincancer, and more. Hacking Dermatology has a winner.
Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be sure to check out PracticalDermatology.com for a bonus video of Drs. Cohen and Martin talking in even greater depth about treating AK.
DermWireTV: LEO Science & Tech Hub, Allergan/SkinBetter DREAM Initiative, San Diego Dermatology Symposium
What is the latest on sunscreen labeling? What are implications of recent serology studies? And could new screening agents come to the US market? Host...
Joel L. Cohen, MD; and Theresa M. Michele, MD
Partner Therapeutics Moves Ahead with Phase 3 Study of Leukine Plus Ipilumimab and Nivolumab for Melanoma
DermaBlade, the easier to grip and use sterile biopsy blade. Watch this video to learn more about DermaBlade from the inventor, Robert Segal, MD.
ISDIN Sunscreen Survey: Just 37% of the US Population Protects Themselves from the Sun on a Daily Basis
New Dermatology Atlas to Highlight and Compare Features of Common Dermatologic Conditions in Different Skin Types
Genentech’s Tecentriq plus Cotellic and Zelboraf Approved for Advanced Melanoma
Study: Pembrolizumab Provides Long-Term Benefits in Patients With Metastatic Melanoma
Pulse Biosciences, Inc.’s Nano-Pulse Stimulation Technology Produces Favorable Results for Warts and All
FDA Approves Merck’s Keytruda for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Not Curable by Surgery or Radiation